Liraglutide for Weight Loss

What is Liraglutide?

Liraglutide is a prescription injectable medication belonging to the class of GLP-1 receptor agonists. Originally developed for type 2 diabetes, it is also FDA-approved for chronic weight management under the brand name Saxenda^®. Liraglutide works by mimicking a hormone (GLP-1) that regulates appetite and metabolism in the body, helping to reduce hunger and calorie intake.

• Administered as a once-daily injection using a pen device.
• Approved for adults with a BMI ≥30, or ≥27 with at least one weight-related condition (such as hypertension or high cholesterol).
• Not a stimulant; works via the body's endocrine system rather than the brain's reward pathways.

How Does Liraglutide Work for Weight Loss?

Liraglutide's effect is grounded in the body's own biology. It binds to and activates GLP-1 receptors—part of the natural glucose regulation system. This slows gastric emptying, prolongs satiety after eating, and decreases hunger signals sent to the brain. In practice, most people find they feel full with smaller meals and experience fewer cravings while on therapy.

• Reduces appetite and calorie intake.
• May lower preference for high-fat, high-sugar foods.
• Helps regulate blood sugar, offering added value for some patients with prediabetes or type 2 diabetes.

Learn more about this class of medications on our page about glp 1 medications.

How Much Weight Can You Lose with Liraglutide?

In clinical trials, people using liraglutide lost an average of 5-10% of their starting weight after one year, particularly when combined with reduced-calorie diets and increased physical activity. For some, results exceeded 10%. Benefits may appear gradually; most weight loss occurs in the first 16-20 weeks, after which weight typically plateaus.

• Weight loss is typically durable when therapy is continued and paired with healthy habits.
• Discontinuing liraglutide often results in some weight regain, a pattern seen with most pharmacotherapies.
• Liraglutide is not a replacement for lifestyle change, but a tool to make adherence easier for many patients.

Compare outcomes for other FDA-approved options on our weight loss medications guide.

What Are the Side Effects of Liraglutide?

Most people tolerate liraglutide well, but side effects are possible—especially during the first weeks of increasing the dose ("titration"). The most common issues are mild to moderate and often improve over time.

• Gastrointestinal: nausea, vomiting, diarrhea, constipation, or decreased appetite.
• Headache and mild dizziness can also occur.
• Rare but serious: pancreatitis, gallbladder disease, kidney problems, and possible increased risk of thyroid tumors (seen in rodents; unclear in humans).

Liraglutide should not be used in people with a personal or family history of certain thyroid cancers or multiple endocrine neoplasia syndrome type 2. Always consult a healthcare professional before starting therapy to discuss your risks.

Liraglutide vs Other Prescription Weight Loss Drugs

Liraglutide stands apart for its mechanism, evidence, and suitability for long-term use. Unlike stimulant pills or orlistat, liraglutide acts on the body's natural satiety pathways. Compared with newer GLP-1s like semaglutide or tirzepatide, its effect size is slightly lower, but it remains an important option—especially for patients who have insurance coverage or who want to avoid dual or triple-agonist drugs.

• Semaglutide (Wegovy^®): Once-weekly GLP-1 agonist with larger average weight loss in trials, but similar side effect profile.
• Orlistat: Non-hormonal pill with modest efficacy and frequent GI side effects. See details on orlistat.
• Tirzepatide: Newer agent (dual GIP/GLP-1), generally reserved for specific cases—see our tirzepatide overview.

For a full comparison of all FDA-approved drugs, visit our prescription weight loss drugs directory.